Rhino HealthTech, Inc.

Founded in 2020 and based in Massachusetts, US, Rhino HealthTech, Inc. operates as a developer of AI-based platform solutions that provide monitoring and maintain AI models intended to help hospitals and health systems in data-driven studies and AI research. Some of the firm's clients include ICHOM, Google Cloud, NTT Data, NVIDIA, etc. The company was co-founded and led by Ittai Dayan (CEO) and Yuval Baror (CTO).

Rhino Health integrates Edge Computing and Federated Learning in healthcare AI through its Federated Computing Platform to streamline healthcare research and AI development. Rhino Health cateres primarily to healthcare, life sciences, and public sector entities. The core of Rhino Health’s offerings lies in its Federated Computing Platform, which supports a range of capabilities including data harmonization, federated training, image annotation, and application development. This platform empowers healthcare innovators to collaborate seamlessly across federated networks, ensuring data sovereignty and compliance with global standards such as ISO 27001, SOC 2, HIPAA, and GDPR.

In May 2025, Rhino HealthTech, Inc. raised USD 15 million in series A funding led by AlleyCorp, with participation from Gaingels, Wilson’s Bird Capital, Arkin Holdings, Fusion Fund, LionBird, Qiming Venture Partners, and TELUS Ventures. Individual investors and other unspecified investors also participated in the round. The company plans to utilize the May 2025 funding customer expansion, sector scale, solution distribution.